Premium
Lipids and lipid‐modifying therapy
Author(s) -
Kirby Mike
Publication year - 2021
Publication title -
trends in urology and men's health
Language(s) - English
Resource type - Journals
eISSN - 2044-3749
pISSN - 2044-3730
DOI - 10.1002/tre.803
Subject(s) - identification (biology) , disease , medicine , key (lock) , secondary prevention , intensive care medicine , biology , ecology , botany
Dyslipidaemia plays a key role in the development of cardiovascular disease (CVD). Therefore, the identification and treatment of dyslipidaemia is important for both primary and secondary CVD prevention, and forms the basis of this article.